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Over the past several decades, rapid developments in both molecular and information technology have collectively
increased our ability to understand molecular recognition. One emerging area of interest in molecular recognition research
includes the isolation of aptamers. Aptamers are single-stranded nucleic acid or amino acid polymers that recognize and
bind to targets with high affinity and selectivity. While research has focused on collecting aptamers and their interactions,
most of the information regarding experimental methods remains in the unstructured and textual format of peer reviewed
publications. To address this, we present the Aptamer Base, a database that provides detailed, structured information
about the experimental conditions under which aptamers were selected and their binding affinity quantified. The open
collaborative nature of the Aptamer Base provides the community with a unique resource that can be updated and curated
in a decentralized manner, thereby accommodating the ever evolving field of aptamer research.
Database URL: http://aptamer.freebase.com
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Introduction
Over the past several decades, rapid developments in both
molecular and information technology have collectively
increased our ability to understand molecular recognition
(1), leading to major implications for drug discovery (2,3).
For example, in vitro screening techniques and adaptive
molecular evolution methods, such as phage display (4),
have made it easier to rapidly screen enormous molecular
libraries to find promising binding ligands (5). Concurrently,
advances in biomedical informatics have made it possible to
harness the power of large datasets and make influential
predictions for molecular recognition (6). Together, the
scalability of information systems coupled with the massive
reduction in the cost, efficiency and time of techniques such
as DNA sequencing (7) will continue to support the expo-
nential growth of information in the field of molecular
biology (8–10).
One emerging area of interest in the quest to under-
stand molecular recognition includes the isolation of apta-
mers. Aptamers are single-stranded nucleic acid or amino
acid polymers that recognize and bind to targets with high
affinity and selectivity. Nucleic acid aptamers are typically
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isolated from large combinatorial libraries containing ap-
proximately 1015 different sequences. This in vitro selection
procedure is usually performed using the Systematic
Evolution of Ligands by Exponential enrichment (SELEX)
process (11,12). The resulting selected aptamers are at
times able to bind to their cognate ligands with dissociation
constants in the picomolar range (13), and can be selected
for a wide variety of targets including small molecules (14),
organic dyes (15), toxins (16), proteins (17,18) and whole
cells (19). As a result, aptamers have emerged as attractive
molecular recognition agents that rival antibodies in
therapeutic (20,21), diagnostic (22) and sensing (23)
applications.
While several efforts have focused on collecting apta-
mers and their interactions (24–26), most of the informa-
tion regarding experimental methods still remains in the
unstructured and textual format of peer reviewed publica-
tions. Furthermore, access to the databases is normally lim-
ited to HTML forms, thereby hindering the type and
number of queries that can be posed against these data-
sets. Additionally, major sequence data providers such as
GenBank (27), EMBL (28) and DDBJ (29) do not maintain a
list of artificially created sequences. Consequently, the com-
munity lacks a data resource in which information about
aptamers, their sequences and the experimental conditions
used in their selection can be stored and queried.
To address this, we present the Aptamer Base, a data-
base that provides detailed, structured information about
the experimental conditions under which aptamers were
selected and their binding affinity quantified. The open
collaborative nature of the Aptamer Base provides the com-
munity with a unique resource that can be updated and
curated in a decentralized manner, thereby accommodat-
ing the ever evolving field of aptamer research.
Materials and Methods
The Aptamer Base was created using Freebase (http://www
.freebase.com), a free, openly licensed community-built
resource for structured data that provides information for
more than 22 million topics. Freebase organizes over 360
million facts into bases, which are collections of thematic-
ally related topics. The Aptamer Base is one such collection
that has been built by a group of expert curators who
manually extracted information on over 157 SELEX-based
experiments from the primary literature published be-
tween 1990 and 2006. Entries in the literature from 2006
to present are added on a weekly basis.
The Aptamer Base data model
Based on the entity-relationship model (30), data in
Freebase is stored as a structured graph in which ‘topics’
represent types or individuals. Every topic is identified by a
unique identifier and is accessible by web browser through
a Uniform Resource Locator (URL). Topics that represent
types can be organized into a type hierarchy using the IS
A relationship. For instance, the RNA Aptamer is a kind of
Aptamer and a kind of RNA, and has access to properties
from both. A type can be related to a property with the
HAS A relationship, and the values of the properties can be
restricted to a particular type. For example, the Dissociation
Constant type HAS A property called ‘is dissociation con-
stant of’ that links to topics only of the Interactor type, as
in http://www.freebase.com/view/m/0cjchc8.
The Aptamer Base data model (Figure 1) is focused on an
Interaction Experiment, which specifies the results and de-
tails of experimental procedures used to identify biomole-
cular interactions.
In the case of aptamers derived from SELEX, the SELEX
Experiment captures the SELEX method used to generate
the sequences, the partitioning method used to discard
non-binding sequences and the recovery method used to
isolate the aptamers from the aptamer–target complex.
Additional details regarding the SELEX experiment, such
as the number of selection rounds, template sequences
and details on the selection solution may also be added.
The entries for the database were carefully selected based
on the methods and results from typical SELEX publications
and as suggested by experts in the field (1,2). Interaction
Experiments may report one or more Interactions. Each
Interaction is related to the participants (Aptamers and
Aptamer Targets) of the reported interaction, through
the ‘has participant’ property. Interaction Experiments can
either ‘confirm’ or ‘dispute’ Interactions under a set of ex-
perimental conditions, thus enabling searching for binding
and/or non-binding sequences. Finally, the strength of an
Interaction is quantified by an Affinity Experiment through
a Dissociation Constant. The curated information included
SELEX experimental conditions, aptamer sequence(s) and
secondary structure predictions, and molecular target
details as extracted from each article (Figure 2).
Our data model makes it possible to describe Minimal
Aptamers, which are sub-sequences or variants of larger
sequences that exhibit binding to a target ligand
(Figure 3). Sequences obtained from SELEX are typically at
least 30 nucleotides in length (31), but it is widely estab-
lished that conserved consensus sequences play an import-
ant role in biological function. Therefore, a minimal
sequence of the full-length aptamer that retains the char-
acteristic function for which the full-length aptamer was
originally selected may be identified. The reported minimal
aptamers participate in Interactions that are distinct from
those of their parent aptamers, thereby permitting the link-
ing of a minimal aptamer–target interaction to a dissoci-
ation constant topic that is distinct from that of its parent.
For every aptamer reported in the Aptamer Base we
have also included its secondary structure as predicted by
RNAFold (32). The resulting predictions are typed as
.............................................................................................................................................................................................................................................................................................
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Predicted Secondary Structure and are associated to
Aptamer topics through the Nucleic Acid type by using
the ‘has predicted secondary structure’ property. The dot
bracket notation, minimum free energy and version of
RNAfold are provided for each prediction (e.g. http://
www.freebase.com/view/m/0gl4r9m). Given that the ‘has
predicted secondary structure’ property is a one-to-many
relation, the Aptamer Base could accommodate the
incorporation of alternative secondary structure predictions
or even tertiary structures made by other prediction pro-
grams (33–35).
Curating the aptamer literature
Approximately 3000 articles from the primary scientific lit-
erature were identified as potential candidates for inclu-
sion in the Aptamer Base. This collection was created by
Figure 1. Basic type-relation map used by the Aptamer Base to describe SELEX experiments. The Interaction Experiment type ‘has
outcome’ an Interaction. Each Interaction ‘has participant’ at least two Interactors (Aptamer and Aptamer Target). The Affinity
Experiment type ‘has outcome’ a Dissociation Constant that either ‘confirms’ or ‘disputes’ an interaction. Blue ellipses denote
types and arrows represent properties between topics. Overlapping ellipses represent the multiple types associated with a topic.
For more details visit http://aptamerbase.semanticscience.org/?q=node/1.
Figure 2. An overview of the relation map used by the Aptamer Base to describe SELEX experiments, the experimental details
and the resulting aptamers. Light blue ellipses denote types and arrows represent either properties between topics or between
topics and values (dark blue rectangles).
.............................................................................................................................................................................................................................................................................................
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performing a general search on PubMed for any articles
containing the terms ‘SELEX’ or ‘aptamer’ in either the
title or abstract. The resulting collection was inspected
manually to ensure that only relevant articles, describing
a SELEX experiment used to generate aptamers, were
assembled for the database entry process. Therefore, all
review papers, articles describing applications of previously
selected aptamers, articles characterizing or modifying
existing aptamers and articles detailing SELEX of in vitro
ribozymes were excluded from the final aptamer database
collection. The final set of 157 articles published between
1990 and 2006 was curated by six expert graduate students,
all of whom have performed experimental research on
aptamers or SELEX.
To ensure curation was consistent and accurate, each
curator was given the same training in extracting relevant
details from aptamer publications. Any curator questions
were directed to both of the first authors and our answers
were then communicated to all curators. Finally, each entry
was verified for completion and accuracy by at least one
other curator, and proper typing of the generated Aptamer
Base topics was programmatically monitored.
At times, information required in our data model was
not present in the primary literature. In some cases this
was due to the particular experimental design chosen by
the author and in other cases due to incomplete informa-
tion presented in the research article. To distinguish
between this and an incomplete entry by one of the cur-
ators, the terms ‘not described’ and ‘not required’ could be
selected.
Results
A data summary of the Aptamer Base
The Aptamer Base currently contains information about
676 interactions involving 928 aptamers, 131 targets and
508 dissociation constants organized into 4143 topics, com-
prising in total approximately 30 000 facts. These facts were
added on a weekly basis between September 2010 and July
2011 (http://activity.freebaseapps.com/domain?id=/base/
aptamer). More specifically, the Aptamer Base describes
interactions involving 328 DNA aptamers and 577 RNA
aptamers, with proteins being the most frequently occur-
ring target type (Figure 4).
Accessing and using the Aptamer Base
Searching and browsing data in the Aptamer Base is pos-
sible in a number of ways. Firstly, we have created a custom
website (http://aptamerbase.semanticscience.org/) which
includes a search interface that directly queries the con-
tents of the Aptamer Base (http://aptamer.freebase.com)
and presents results via a simple user-friendly search
form. Here, the user can narrow his or her search of the
almost 1000 aptamer topics by specifying an aptamer type
Figure 3. Overview of an abridged relation map describing minimal aptamers. Minimal aptamers are captured in the Aptamer
Base by creating a new Interaction for each individual Minimal Aptamer, permitting the description of unique Aptamers can
then be associated with the unique Interaction topics.
.............................................................................................................................................................................................................................................................................................
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(DNA, RNA or peptide) and/or a target type of interest (see
list in Figure 4). Users can also specify a target name in their
search by inputting all or part of the target name. The user
can choose from a list of available options, which are
auto-completed by Freebase Suggest (http://www.free
base.com/docs/suggest). PubMed identifiers can also be spe-
cified to limit the search to specific publications. Our
custom website also provides users with documentation
on using and accessing the data in the Aptamer Base.
Secondly, users have programmatic access to the
Aptamer Base through the Freebase application program-
ming interface (API) (http://www.freebase.com/docs/data).
The Freebase API allows users to query the Aptamer Base
using the Metaweb Query Language (MQL), a powerful
tool that allows users to formulate complex queries
that are not limited to the type-based searches possible
through our search interface. Using the API, queries are
serialized as JavaScript Object Notation (JSON) through a
Representational State Transfer (REST) interface. A sample
MQL query to retrieve all RNA aptamer sequences in the
Aptamer Base is shown in Box 1, along with an abridged
result set in Table 1.
Data in Freebase is also available as part of the Linking
Open Data (LOD) project (36), a community effort that col-
lects data from various open data sources on the Web and
publishes and interlinks the different sources using the
Resource Description Framework (RDF) (37) in a dereferenc-
able manner. As such, any topic in Freebase and specifically
in the Aptamer Base can be retrieved as RDF/XML by using
the following URL: http://rdf.freebase.com/rdf/[TOPIC_ID],
where TOPIC_ID is the unique identifier given by Freebase
to a topic.
Finally, full data dumps of the Aptamer Base are avail-
able as tab-delimited files from http://download.freebase
.com/datadumps/latest/browse/base/aptamer/.
Discussion
We have described the Aptamer Base, a new collaboratively
developed knowledge base motivated by the information
needs of aptamer researchers. The Aptamer Base provides
detailed, structured information about the experimental
conditions under which aptamers were selected and their
binding affinity quantified. Our data model provides the
required types and properties to capture experimental
details of both the partitioning of non-binding sequences
from a sequence library and the recovery of binding se-
quences from aptamer-target complexes in SELEX experi-
ments. The Aptamer Base also describes the pH,
temperature, salt concentration and the buffering agent
for all SELEX experiments. Providing access to these experi-
mental conditions is crucial in ensuring the reproducibility
of the reported experiments (38). This information can be
Box 1: Sample MQL query to retrieve all RNA aptamer
sequences that are interactors and their respective target
names. Note that all types must be specified since
Freebase does not make use of a type hierarchy. MQL
queries can be posed on Freebase data using their query
editor found at http://www.freebase.com/queryeditor.
Additional queries can be found the supplementary
materials.
[{
‘‘id’’:null,
‘‘type’’:‘‘/base/aptamer/aptamer’’,
‘‘a:type’’:‘‘/base/aptamer/linear_polymer’’,
‘‘b:type’’:‘‘/base/aptamer/interactor’’,
‘‘c:type’’:‘‘/base/aptamer/rna’’,
‘‘/base/aptamer/linear_polymer/sequence’’:null,
‘‘/base/aptamer/interactor/is_participant_in’’:[{
‘‘/base/aptamer/interaction/has_participant’’:[{
‘‘d:type’’:‘‘/base/aptamer/aptamer_target’’,
‘‘name’’:null
}]
}]
}]
Figure 4. Summary of target types and aptamer types found in the Aptamer Base. (A) Distribution of the over 900 aptamer types
described by the Aptamer Base. (B) Distribution of the 131 aptamer targets found in the Aptamer Base.
.............................................................................................................................................................................................................................................................................................
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leveraged by aptamer researchers wishing to either repro-
duce or select new aptamers. For example, researchers at-
tempting to develop aptamers for a specific target can
query the Aptamer Base for the conditions of successful
SELEX experiments for identical or similar targets.
While earlier efforts at creating databases about apta-
mers have been documented (24–26), the Aptamer Base
provides significant benefits beyond these in several re-
spects. Firstly, it is a part of the larger resource that is
Freebase. We have chosen to use Freebase to host the
Aptamer Base for a variety of reasons: it provides users
with an intuitive interface that readily permits the editing
and addition of data, there is a stable community of over
58 000 users that contribute to Freebase on a daily basis,
data in Freebase can be queried using the flexible query
language MQL, and data stored in this resource is export-
able into other data formats (RDF/XML, JSON or text).
Secondly, data entry and curation of the Aptamer Base
can be undertaken by any registered member of
Freebase. This unique feature enables researchers, educa-
tors and students within and outside of the aptamer com-
munity to contribute and make use of the knowledge in
the Aptamer Base. Like other successful open data projects
such as Wikipedia, Freebase relies on community collabor-
ation to maintain a complete and accurate dataset. Users
can correct or augment facts in the Aptamer Base, but may
be suspended if in violation of basic Freebase content
creation guidelines (see http://wiki.freebase.com/wiki/
Contribution_guidelines). Furthermore, administrators of
the Aptamer Base can at any point modify, remove or
undo changes to any entry to ensure data quality and con-
sistency To this end, Freebase provides the community with
the ability to revert any changes made to the Aptamer Base
through the use of Freebase datadumps (http://download
.freebase.com/datadumps/), which have complete backups
of the data in Freebase for the previous two months. Access
to older backups is also available by contacting the
Freebase staff.
The Aptamer Base also reuses knowledge that is already
in Freebase. Our dataset includes types and topics that have
been contributed by the community. For example, we reuse
information from Chemistry Commons (http://freebase
.com/view/chemistry) to provide links to PubChem and
Wikipedia for the majority of aptamer target topics. By
choosing to use types and topics already found in
Freebase, our curators can save time in the creation of
new relevant topics. In addition, curators can ascribe to
the community consensus on particular topics and conse-
quently enhance these topics by providing new contextua-
lized knowledge about them. Similarly, the 12 registered
members of the Aptamer Base have created types that
have been reused by the Freebase staff to annotate 285
Wikipedia articles (http://www.freebase.com/view/base/
aptamer/views/rna).
Programmatic access to Freebase data through either the
REST interface or their hosted development environment
Acre (http://wiki.freebase.com/wiki/Acre) enables its users
to create data ‘mashups’ via web applications that use
and combine data from different bases in Freebase. These
can be combined with external resources to further en-
hance the knowledge hosted on Freebase. For example,
when possible, we provide links to the Chemical Entities
of Biological Interest database (ChEBI, available at: http://
www.ebi.ac.uk/chebi/) (39), by associating reported
small-molecule ligand Interactors with their corresponding
ChEBI identifiers. These identifiers can be used to query
ChEBI’s Simple Object Access Protocol (SOAP) interface to
extract further information.
The expandable nature of the data model used by the
Aptamer Base has been tailored to provide a core set of the
necessary details required to generically reproduce SELEX
experiments (38). However, the relatively young stage of
aptamer in vitro experiments has inevitably resulted in pub-
lications with varying levels of detail. Consequently, the
data stored in the Aptamer Base is only as detailed as the
publication of origin. Our data model can therefore be
used as a common set of requirements for reporting
future in vitro aptamer experiments and subsequently ex-
panded to accommodate results of other in vitro sequence
evolution experiments that involve biomolecular
Table 1. Abridged list of Aptamer Base topics returned by the query shown in Box 1. The types of the results are not displayed.
Topics can be viewed by visiting http://www.freebase.com/view/ [TOPIC_ID]
Topic ID Target Name Aptamer Sequence
/m/0cvjvjp Tetracycline GGCCUAAAACAUACCAGAUUUCGAUCUGGAGAGGUGAAGAAUUCGACCACCUAGGCC
GGU
/m/0cx03px Dopamine GGGAAUUCCGCGUGUGCGCCGCGGAAGACGUUGGAAGGAUAGAUACCUACAACGGGG
AAUAUAGAGGCCAGCACAUAGUGAGGCCCUCCUCCCAAGGUCCGUUCGGGAUCCUC
/m/0cysc2w Human epidermal growth factor
receptor 3
CAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCG
/m/0czndxr Human activated protein C GUGAGACCAGCCGAGUGGUGUCUGGCUAUUCACUGGAGCGUGGGUGGAACCCCUGCG
CACUCGUUUGGCUGUCCGGGCCUUCGGGCCGGGAUUAUCUCU
.............................................................................................................................................................................................................................................................................................
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interactions such as phage display (4) and the development
of ribozymes.
Although SELEX identifies putative aptamer sequences,
not all have been verified with a binding affinity experi-
ment. As a result, there is always a possibility that these
sequences actually have little or no affinity for the target,
but have nonetheless been included in an aptamer data-
base. Towards higher quality data, most Aptamer Base
Aptamers have been verified by some Affinity Experiment
are stated to either bind (‘confirm’) or not to bind to the
target (‘dispute’) in question.
With the Aptamer Base, we hope to address the gap that
exists in available data resources for in vitro selected se-
quences. As the biological significance of aptamers be-
comes better understood, we anticipate that the Aptamer
Base will become increasingly important. Rapid advances in
structural biology towards the discovery of novel biochem-
ical functions including structure, function and interactions
are providing a wealth of information that needs to be
accessible by structured queries, whether through simple
or programmatic interfaces. The Aptamer Base, through
its open framework for accessing and contributing data,
promises to not only provide accurate and up to data for
aptamer scientists, but also a new resource for bioinformat-
ics research and discovery.
Supplementary data
Supplementary data are available at Database online.
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